日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

LDLR c.415G > A 通过削弱 LDLR 与 LDL 的结合,导致家族性高胆固醇血症

Kaihan Wang #, Tingting Hu #, Mengmeng Tai #, Yan Shen, Haocheng Chai, Shaoyi Lin, Xiaomin Chen

Pathogenicity of the LDLR c.97C>T (p.Gln33Ter) Mutation in Familial Hypercholesterolemia

家族性高胆固醇血症中 LDLR c.97C>T (p.Gln33Ter) 突变的致病性

Kaihan Wang, Tingting Hu, Mengmeng Tai, Yan Shen, Shaoyi Lin, Yongjuan Guo, Xiaomin Chen

In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia

家族性高胆固醇血症中 LDLR c.2160delC 变异的致病性的体外评估

Shaoyi Lin #, Tingting Hu #, Kaihan Wang #, Jiaqi Wang, Yunyun Zhu, Xiaomin Chen

FGF23 alleviates neuronal apoptosis and inflammation, and promotes locomotion recovery via activation of PI3K/AKT signalling in spinal cord injury

FGF23 减轻神经元凋亡和炎症,并通过激活脊髓损伤中的 PI3K/AKT 信号传导促进运动恢复

Yan Cui, Bin Yang, Shaoyi Lin, Luqiang Huang, Feibin Xie, Wei Feng, Zhenzong Lin

The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia

LDLR c.501C>A 是家族性高胆固醇血症的致病变异

Haochang Hu #, Ruoyu Chen #, Yingchu Hu, Jian Wang, Shaoyi Lin, Xiaomin Chen

The expression profile of platelet-derived miRNA in coronary artery disease patients with clopidogrel resistance

氯吡格雷抵抗冠心病患者血小板衍生miRNA表达谱

Shaoyi Lin, Xiaofeng Xu, Haochang Hu, Ji Cheng, Ruoyu Chen, Yingchu Hu, Xiaomin Chen

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia

家族性高胆固醇血症的 LDLR 中两种新的致病突变

Haochang Hu, Tian Shu, Jun Ma, Ruoyu Chen, Jian Wang, Shuangshuang Wang, Shaoyi Lin, Xiaomin Chen